The American College of Cardiology has declared that chronic inflammation is central to cardiovascular disease and must now be measured and treated as part of standard care.
Routine blood pressure readings in clinical practice are frequently inaccurate. Pharmacies offer a smarter, more accurate alternative for cardiovascular screening.
A recent study validates waist circumference as a superior indicator of cardiovascular disease risk compared to body mass index.
The CardiAction Risk Algorithm is built on three validated principles centred on central systolic pressure measurement and prevention.
Heart disease is the leading cause of death for women in Australia and globally, yet it remains under-recognised and under-treated.
Over 70 years of studies have demonstrated the Mediterranean Diet's benefits for weight management, chronic disease prevention, and cardiovascular health.
Research suggests being fit, even while overweight, can reduce some negative health effects of obesity, challenging traditional assumptions.
Exploring how genetic makeup influences cardiovascular health and how nutrigenomics can guide personalised dietary interventions.
Evaluating popular diets including keto, intermittent fasting, and plant-based approaches through the lens of cardiovascular science.
Recent studies show that regular caffeinated coffee consumption is associated with reduced heart failure risk, while decaf does not show the same benefit.
Re-examining the long-held belief that saturated fats directly cause arterial blockages in light of modern cardiovascular research.
A scientific update on why cardiovascular risk in women requires different assessment approaches and how CardiAction addresses this gap.
Low vitamin D levels in aging men are linked to increased cardiovascular risk, and screening can help identify this often-overlooked factor.
Why central systolic pressure measurement represents a significant advancement in how we assess and prevent cardiovascular disease.
Non-invasive central blood pressure measurement via pharmacy screening reveals aortic pressure insights that traditional arm-cuff readings miss, offering a stronger predictor of cardiovascular events.
Community pharmacy screening is transforming cardiovascular prevention by delivering accessible, non-invasive heart health checks where people already visit.
CardiAction Screening Australia grows its pharmacy heart screening network, bringing non-invasive cardiovascular prevention to more communities nationwide.
CardiAction ProScreen data shows approximately 30% of individuals had clinically meaningful central blood pressure findings despite normal brachial readings.
CardiAction ProScreen delivers a heart health action plan for immediate cardiovascular risk reduction, creating a genuine screen-act-improve cycle.
Pulse Wave Analysis measures central blood pressure and arterial stiffness with a simple arm cuff, revealing what a standard blood pressure check can miss.
